Newsroom

BigHat founder discusses COVID-19's impact on early-stage startups

Read more

BigHat co-founder Peyton Greenside joins a panel discussion, along other leaders from Silicon Valley Bank, Civilization Ventures, Pivotal Bioventure Partners, BioRock Ventures, to discuss: Is this The Lost Year for Startups, or the Year of Greatest Opportunity?

2020 has brought renewed focus to the promise of biotech and the ability of novel therapeutics to meet society's urgent needs. It has also highlighted the current limits of science, the fragility of our health care system, and the long process from R&D to market for new drugs. What does this all mean for you and your startup, and how will you thrive amidst the uncertainty? Our expert VC/CEO panelists weigh in with concrete advice and stories from the trenches.